Home / PPBT : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does PPBT make money? Does PPBT have pricing power? What's the Earnings Whisper? Will PPBT profit more as the business scales? What is PPBT's management track record? Is PPBT's current price justified?

Purple Biotech Ltd.

$1.72 -$4.88 (-73.94%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$1.74

Day Range

$1.62$1.79

Year Range

$1.16$14.1

Market Cap

237.5K

AVG Volume

1.11M

Trailing/Forward PE

-0.01/-

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-13

Primary Exchange

NASDAQ

Revenue (USD)

PPBT Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	0
25 Q2	0
25 Q1	0
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD)

PPBT Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	441K
26 Q1	-86K
25 Q4	-23.55M
25 Q3	-1.3M
25 Q2	-1.08M
25 Q1	-453K
24 Q4	-410K
24 Q3	-663K
24 Q2	-2.4M
24 Q1	-3.76M

Operating Income (USD)

PPBT Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-1.3M
26 Q1	-2.25M
25 Q4	-23.45M
25 Q3	-1.37M
25 Q2	-1.24M
25 Q1	-1.41M
24 Q4	-1.02M
24 Q3	-2.13M
24 Q2	-3.46M
24 Q1	-4.47M

EBITDA (USD)

PPBT EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	520K
26 Q1	7K
25 Q4	-23.57M
25 Q3	-1.24M
25 Q2	-1.04M
25 Q1	-376K
24 Q4	-886K
24 Q3	-108K
24 Q2	-2.34M
24 Q1	-3.72M

Cash Flows (USD)

PPBT Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-2.51M
26 Q1	-3.12M
25 Q4	-1.07M
25 Q3	-1.06M
25 Q2	-1.55M
25 Q1	-1.98M
24 Q4	-2.01M
24 Q3	-3.29M
24 Q2	-3.98M
24 Q1	-5.08M

EPS (USD)

PPBT EPS (USD) by quarter
Period	EPS (USD)
26 Q2	0.04
26 Q1	0
25 Q4	-1.98
25 Q3	-0.28
25 Q2	-0.4
25 Q1	-0.18
24 Q4	-2
24 Q3	-3.8
24 Q2	-17.4
24 Q1	-27.8

Expenses (USD)

PPBT Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	1.3M
26 Q1	2.25M
25 Q4	2.7M
25 Q3	1.37M
25 Q2	1.24M
25 Q1	1.41M
24 Q4	768K
24 Q3	2.13M
24 Q2	3.26M
24 Q1	4.47M

Cash & Debt (USD)

PPBT Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	6.11M
26 Q1	6.43M
25 Q4	9.57M
25 Q3	10.45M
25 Q2	5.92M
25 Q1	7.09M
24 Q4	8.52M
24 Q3	6.3M
24 Q2	7.39M
24 Q1	10.85M

Debt ratios

PPBT Debt ratios by quarter
Period	Debt ratios
26 Q2	0.25
26 Q1	0.24
25 Q4	0.36
25 Q3	2.88
25 Q2	2.41
25 Q1	1.87
24 Q4	1.18
24 Q3	0.55
24 Q2	0.44
24 Q1	0.57

Margins

PPBT Margins by quarter
Period	Margins
20 Q2	100%
20 Q1	100%
19 Q2	100%
19 Q1	100%
18 Q2	100%
18 Q1	100%
17 Q4	100%
17 Q3	100%

Return on Capital

PPBT Return on Capital by quarter
Period	Return on Capital
26 Q2	3.61%
26 Q1	-0.89%
25 Q4	-243.76%
25 Q3	-3.97%
25 Q2	-3.39%
25 Q1	-1.39%
24 Q4	-1.25%
24 Q3	-2.25%
24 Q2	-8.19%
24 Q1	-12.1%

Shares Outstanding

PPBT Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	10.86M
26 Q1	9.35M
25 Q4	11.91M
25 Q3	4.56M
25 Q2	2.74M
25 Q1	2.63M
24 Q4	205.21K
24 Q3	173.29K
24 Q2	137.66K
24 Q1	135.57K

Book Value Per Share (USD)

PPBT Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	1.12
26 Q1	1.03
25 Q4	0.81
25 Q3	7.2
25 Q2	11.71
25 Q1	12.41
24 Q4	160.38
24 Q3	170.05
24 Q2	213.4
24 Q1	229.34

Total Assets (USD)

PPBT Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	14.17M
26 Q1	14.42M
25 Q4	17.57M
25 Q3	39.06M
25 Q2	34.38M
25 Q1	35.59M
24 Q4	37.04M
24 Q3	35.1M
24 Q2	36.06M
24 Q1	39.86M

Employee Count

PPBT Employee Count by quarter
Period	Employee Count
2025	10
2024	9
2023	20
2022	20
2021	19
2020	13
2019	9
2018	10
2017	9
2016	7

Free Cash Flow Yield

PPBT Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-41.55%
Sep 26	-40.83%
Aug 26	-42.54%
Aug 26	-45.52%
Aug 26	-47.64%
Aug 26	-49.97%
Jul 26	-51.98%
Jul 26	-50.89%
Jul 26	-49.5%
Jul 26	-46.64%
Jul 26	-42.8%
Jun 26	-43.31%
Jun 26	-42.8%
Jun 26	-46.05%
Jun 26	-24.5%
May 26	-24.34%
May 26	-25.27%
May 26	-18.47%
May 26	-11.51%
May 26	-11.31%
Apr 26	-10.47%
Apr 26	-9.76%
Apr 26	-11.51%
Apr 26	-11.56%
Mar 26	-11.85%
Mar 26	-11.94%
Mar 26	-11.59%
Mar 26	-30.32%
Feb 26	-32.79%
Feb 26	-29.28%
Feb 26	-25.03%
Feb 26	-24.08%
Jan 26	-24%
Jan 26	-21.83%
Jan 26	-22.9%
Jan 26	-20.97%
Jan 26	-21.96%
Dec 25	-20.53%
Dec 25	-20.5%
Dec 25	-19.27%
Dec 25	-17.44%
Nov 25	-39.07%
Nov 25	-42.13%
Nov 25	-44.95%
Nov 25	-39.45%
Oct 25	-41.11%
Oct 25	-54.7%
Oct 25	-53.08%
Oct 25	-54.7%
Oct 25	-54.33%
Sep 25	-53.87%
Sep 25	-55.35%
Sep 25	-56.62%
Sep 25	-48.9%
Aug 25	-16.22%
Aug 25	-14.06%
Aug 25	-13.97%
Aug 25	-15.15%
Aug 25	-19.71%
Jul 25	-18.35%
Jul 25	-16.45%
Jul 25	-17.82%
Jul 25	-17.24%
Jun 25	-18.28%
Jun 25	-18.59%
Jun 25	-17.45%
Jun 25	-16.35%
May 25	-16.45%
May 25	-291.96%
May 25	-308.43%
May 25	-317.52%
May 25	-301.78%
Apr 25	-259.31%
Apr 25	-246.52%
Apr 25	-280.05%
Apr 25	-271.89%
Mar 25	-252.3%
Mar 25	-255.99%
Mar 25	-256.93%
Mar 25	-356%
Feb 25	-335.69%
Feb 25	-315.57%
Feb 25	-322.7%
Feb 25	-333.45%
Jan 25	-307.8%
Jan 25	-273.32%
Jan 25	-282.59%
Jan 25	-257.16%
Jan 25	-221.81%
Dec 24	-229.44%
Dec 24	-292.5%
Dec 24	-261.19%
Dec 24	-213.3%
Nov 24	-298.17%
Nov 24	-586.93%
Nov 24	-513.12%
Nov 24	-457.43%
Nov 24	-413.3%
Oct 24	-313.51%
Oct 24	-294.14%

Price to Sales

PPBT Price to Sales by quarter
Period	Price to Sales
Aug 21	164.04
Aug 21	160.22
Aug 21	164.04
Aug 21	175.51
Jul 21	191.85
Jul 21	172.04
Jul 21	173.77
Jul 21	163.35
Jul 21	165.43
Jun 21	172.04
Jun 21	177.25
Jun 21	174.82
Jun 21	206.1
May 21	48.52
May 21	42.12
May 21	35.72
May 21	35.28
Apr 21	37.5
Apr 21	40.43
Apr 21	34.3
Apr 21	38.66
Apr 21	37.59
Mar 21	37.41
Mar 21	41.32
Mar 21	43.1
Mar 21	36.79
Feb 21	42.21
Feb 21	52.7
Feb 21	52.79
Feb 21	42.3
Jan 21	35.28
Jan 21	40.97
Jan 21	38.75
Jan 21	35.55
Dec 20	33.86
Dec 20	36.7
Dec 20	36.26
Dec 20	37.06
Dec 20	37.24
Nov 20	25.36
Nov 20	24.4
Nov 20	24.94
Nov 20	24.58
Oct 20	24.88
Oct 20	28.42
Oct 20	26.02
Oct 20	26.8
Oct 20	26.02
Sep 20	24.4
Sep 20	25.78
Sep 20	25.24
Sep 20	24.64
Aug 20	26.86
Aug 20	28.66
Aug 20	31.69
Aug 20	52.28
Jul 20	48.23
Jul 20	45.07
Jul 20	46.21
Jul 20	49.32
Jul 20	55.88
Jun 20	69.7
Jun 20	34.19
Jun 20	26.97
Jun 20	29.92
May 20	13.11
May 20	15.15
May 20	13.67
May 20	12.64
May 20	9.74
Apr 20	8.77
Apr 20	10.72
Apr 20	10.02
Apr 20	8.14
Mar 20	9.55
Mar 20	6.96
Mar 20	6.43
Mar 20	16
Feb 20	11.73
Feb 20	12.51
Feb 20	14.66
Feb 20	13.88
Jan 20	14.27
Jan 20	16.23
Jan 20	16.42
Jan 20	16.35
Jan 20	15.34
Dec 19	14.86
Dec 19	14.47
Dec 19	13.65
Dec 19	14.1
Nov 19	14.47
Nov 19	13.81
Nov 19	13.62
Nov 19	13.58
Nov 19	14.62
Oct 19	14.04
Oct 19	14.36
Oct 19	13.81
Oct 19	14.25

Price to Book

PPBT Price to Book by quarter
Period	Price to Book
Sep 26	1.53
Sep 26	1.56
Aug 26	1.49
Aug 26	1.4
Aug 26	1.33
Aug 26	1.27
Jul 26	1.35
Jul 26	1.38
Jul 26	1.42
Jul 26	1.51
Jul 26	1.64
Jun 26	1.63
Jun 26	1.64
Jun 26	1.53
Jun 26	2.87
May 26	2.89
May 26	2.79
May 26	3.81
May 26	5.09
May 26	5.18
Apr 26	5.6
Apr 26	6
Apr 26	5.09
Apr 26	5.07
Mar 26	4.94
Mar 26	4.91
Mar 26	5.06
Mar 26	0.66
Feb 26	0.61
Feb 26	0.69
Feb 26	0.8
Feb 26	0.84
Jan 26	0.84
Jan 26	0.92
Jan 26	0.88
Jan 26	0.96
Jan 26	0.92
Dec 25	0.98
Dec 25	0.98
Dec 25	1.04
Dec 25	1.15
Nov 25	0.71
Nov 25	0.65
Nov 25	0.61
Nov 25	0.7
Oct 25	0.67
Oct 25	0.5
Oct 25	0.52
Oct 25	0.5
Oct 25	0.51
Sep 25	0.51
Sep 25	0.5
Sep 25	0.49
Sep 25	0.56
Aug 25	1.7
Aug 25	1.96
Aug 25	1.97
Aug 25	1.82
Aug 25	1.75
Jul 25	1.88
Jul 25	2.09
Jul 25	1.93
Jul 25	2
Jun 25	1.88
Jun 25	1.85
Jun 25	1.97
Jun 25	2.11
May 25	2.09
May 25	0.15
May 25	0.14
May 25	0.14
May 25	0.14
Apr 25	0.17
Apr 25	0.18
Apr 25	0.16
Apr 25	0.16
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Mar 25	0.17
Feb 25	0.18
Feb 25	0.19
Feb 25	0.18
Feb 25	0.18
Jan 25	0.19
Jan 25	0.22
Jan 25	0.21
Jan 25	0.23
Jan 25	0.27
Dec 24	0.26
Dec 24	0.2
Dec 24	0.23
Dec 24	0.28
Nov 24	0.2
Nov 24	0.1
Nov 24	0.12
Nov 24	0.13
Nov 24	0.15
Oct 24	0.19
Oct 24	0.2

No video analysis for this stock yet. Request one from our team.

News: PPBT

globenewswire.com · 2 Sep 2026

New U.S. Patent Allowance Strengthens Protection for CAPTN-3 Modular Platform for Next-Generation Multispecific Antibodies

REHOVOT, Israel, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the “Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing a next-generation immunotherapy platform designed to maximize anti-cancer activity while minimizing toxicity, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application covering tri-specific antibody constructs and methods of use. The patent allowance further expands the Company's intellectual property portfolio supporting its proprietary CAPTN-3 platform for conditionally activated multispecific antibodies.

defenseworld.net · 31 Aug 2026

Financial Review: Ionis Pharmaceuticals (NASDAQ:IONS) & Purple Biotech (NASDAQ:PPBT)

Ionis Pharmaceuticals (NASDAQ: IONS - Get Free Report) and Purple Biotech (NASDAQ: PPBT - Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation and analyst recommendations. Earnings and Valuation This table compares Ionis Pharmaceuticals

defenseworld.net · 4 Aug 2026

Purple Biotech (PPBT) Expected to Announce Quarterly Earnings on Wednesday

Purple Biotech (NASDAQ: PPBT - Get Free Report) will likely be announcing its results before the market opens on Wednesday, August 5th. Analysts expect Purple Biotech to announce earnings of ($0.98) per share for the quarter. Purple Biotech (NASDAQ: PPBT - Get Free Report) last announced its quarterly earnings data on Saturday, May 16th. The company reported